New Frontiers in Subcutaneous Immunoglobulin Treatment

Subcutaneous immunoglobulin (SCIG) treatment provides stable serum immunoglobulin G (IgG) levels, is associated with fewer systemic adverse events than intravenous immunoglobulin (IVIG) treatment, and offers the convenience of home therapy. In clinical practice, IVIG is still used preferentially for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jolles, Stephen, Stein, Mark R., Longhurst, Hilary J., Borte, Michael, Ritchie, Bruce, Sturzenegger, Matthias H., Berger, Melvin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Healthcare Communications 2011
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3873072/
https://ncbi.nlm.nih.gov/pubmed/24392293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13554-011-0009-3
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge